Entrepreneur
Business And Immigration Investment · 2025-01-15
Framework Evaluation
0 of 3 criteria metThe petitioner waived her claim to this criterion on appeal, effectively conceding the Director's finding that it was not met.
The submitted articles were found deficient due to not being about the petitioner, being paid advertisements, lacking author/date information, or being published after the petition's filing date, thus failing to meet regulatory requirements.
The petitioner failed to provide objective evidence to corroborate claims in reference letters, and the contributions, while beneficial to clients, were not demonstrated to have 'major significance' to the overall field of business and immigration investment.
The article in 'Science and Life' was not deemed scholarly as it lacked original research/experimentation, and the publication itself was not considered a professional or major trade publication for the petitioner's field due to its broad, non-specialized content.
Why This Petition Was Denied
Request for Evidence (RFE)
Unsuccessfully AddressedThe RFE requested further evidence for the petitioner's original contributions of major significance. In response, the petitioner submitted four additional letters, with three detailing her 'one-stop-shop' business strategy for clients and one providing a personal account of benefits received from her services.
Evidence
- Published material (articles from Shenzhen Special Zone Daily, haiwai.net.cn, NetEase, ifeng.com, sohu.com, qq.com)
- Reference letters
- Professional plan
- Scholarly articles (article in Science and Life)
Similar Cases
Entrepreneur
Consulting
Lawyer
Legal Services
Entrepreneur
Others
Entrepreneur
Food and Beverage
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-15.
Browse all casesAt a Glance
EB-1A Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist